Menadione

Menadione

SCHEMBL1364028

CC1=CC(=O)c2ccccc2C1=O.CC1=CC(=O)c2ccccc2C1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 1.00
ALDH1A1 P00352 5/20 1.00
MEN1 O00255 5/20 1.00
KMT2A Q03164 5/20 1.00
MAPK1 P28482 5/20 1.00
LMNA P02545 5/20 1.00
CDC25B P30305 4/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
IDO1 P14902 3/20 1.00
CDC25A P30304 3/20 1.00
HPGD P15428 3/20 1.00
BLM P54132 3/20 1.00
TP53 P04637 2/20 1.00
CYP1A2 P05177 2/20 1.00
CYP3A4 P08684 2/20 1.00
HSPD1 P10809 2/20 1.00
HSPE1 P61604 2/20 1.00
TST Q16762 2/20 1.00
GAA P10253 2/20 1.00
ATM Q13315 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Menadione SCHEMBL29351164 1.00 MAPT (1.00) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL19356853 1.00 MAPT (1.00) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL25970 1.00 MAPT (1.00) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL9807661 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL9812440 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL9163371 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL28388399 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL6680739 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL3411128 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1
Menadione SCHEMBL28234760 0.98 MAPT (0.95) MAPTALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8568694-B2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-10-29 US disclosed
US-8569482-B2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-10-29 US disclosed
US-8066973-B2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-11-29 US disclosed
US-20100172843-A1 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-07-08 US disclosed
US-7662362-B2 Paramagnetic spin probes; useful for magnetic resonance imaging techinques, including electron paramagnetic resonance (EPR) and magnetic resonance imaging (MRI); lithium phthalocyanine derivatives THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-02-16 US disclosed
EP-1991120-A2 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION THE OHIO STATE UNIVERSITY (US) 2008-11-19 EP disclosed
WO-2007103706-A2 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION THE OHIO STATE UNIVERSITY (US) 2007-09-13 WO disclosed
US-20070041909-A1 Nanoparticulate probe for in vivo monitoring of tissue oxygenation THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2007-02-22 US disclosed
EP-1677676-A2 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2006-07-12 EP disclosed
US-20050203292-A1 Paramagnetic spin probes; useful for magnetic resonance imaging techinques, including electron paramagnetic resonance (EPR) and magnetic resonance imaging (MRI); lithium phthalocyanine derivatives NIH - DEITR 2005-09-15 US disclosed
WO-2005024442-A2 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2005-03-17 WO disclosed
EP-0247513-B1 PROCESS FOR PRODUCING 2-METHYL-1,4-NAPHTHOQUINONE Eisai Chemical Co., Ltd. (JP) 1991-09-11 EP disclosed
EP-0247513-A1 Process for producing 2-methyl-1,4-naphthoquinone Eisai Chemical Co., Ltd. (JP) 1987-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100172843-A1 NANOPARTICULATE PROBE FOR IN VIVO MONITORING OF TISSUE OXYGENATION LPO, TNNC1, PPOX MAPT 1346/4885ALDH1A1 3305/4885MEN1 1340/4885
US-20070041909-A1 Nanoparticulate probe for in vivo monitoring of tissue oxygenation LPO, TNNC1, PPOX MAPT 1225/4885ALDH1A1 3359/4885MEN1 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.